Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers
- Benitec Biopharma Inc. (NASDAQ:BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.
- TRxADE HEALTH, Inc. (NASDAQ:MEDS) shares jumped 91.9% to $16.20. TRxADE HEALTH issued correction to press release announcing its anticipated combination with Superlatus, Inc.
- MoonLake Immunotherapeutics (NASDAQ:MLTX) gained 75% to $45.50 after the company's Phase 2 study for Nanobody sonelokimabint met its primary endpoint in hidradenitis suppurativa.
- INVO Bioscience, Inc. (NASDAQ:INVO) shares jumped 41% to $0.2327 after dropping 5% on Friday.
- iMedia Brands, Inc. (NASDAQ:IMBI) gained 35% to $0.1891. iMedia Brands announced receipt of second Nasdaq non-compliance notice.
- Acelyrin, Inc. (NASDAQ:SLRN) shares climbed 35% to $23.81.
- Digital Media Solutions, Inc. (NYSE:DMS) shares gained 26% to $0.4234 after gaining around 5% on Friday. Digital Media Solutions recently reported slightly worse-than-expected Q1 sales results.
- BioRestorative Therapies, Inc. (NASDAQ:BRTX) jumped 24.6% to $7.13.
- Whole Earth Brands, Inc. (NASDAQ:FREE) climbed 21.6% to $3.7932 after a 13D filing showed Martin Franklin delivered a non-binding proposal to Mr. Irwin Simon, the Executive Chairman of the board of directors of Whole Earth, to acquire the company for $4 per share in cash.
- Kubient, Inc. (NASDAQ:KBNT) surged 17.7% to $0.5650.
- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) rose 17% to $7.59. ORIC Pharmaceuticals announced $85 million private placement financing.
- Identiv, Inc. (NASDAQ:INVE) gained 15.7% to $8.31. B. Riley Securities upgraded Identiv from Neutral to Buy and raised the price target from $10 to $11.
- Better Choice Company Inc. (NYSE:BTTR) climbed 15.6% to $0.2474.
- SL Green Realty Corp. (NYSE:SLG) gained 15.5% to $27.19.
- SQZ Biotechnologies Company (NYSE:SQZ) shares gained 15% to $0.46 after dropping around 23% on Friday.
- Super League Gaming, Inc. (NASDAQ:SLGG) rose 13.8% to $0.4498.
- Lucid Group, Inc. (NASDAQ:LCID) gained 13% to $6.18 after the company announced a technology partnership with Aston Martin to integrate, supply Lucid's electric vehicle powertrain and battery systems in contracts worth in excess of $450 million.
- Altice USA, Inc. (NYSE:ATUS) jumped 11.7% to $2.38.
- Femasys Inc. (NASDAQ:FEMY) gained 11.2% to $0.6799 after the company announced FDA approval of its IDE for the pivotal clinical trial of FemBloc permanent birth control, a non-surgical alternative for women.
- IonQ, Inc. (NYSE:IONQ) rose 10.1% to $10.32. Needham maintained IonQ with a Buy and raised the price target from $9 to $11.
- PacWest Bancorp (NASDAQ:PACW) gained 10% to $7.95 after Ares Management acquired the bank's $3.5 billion specialty finance loan portfolio.
- Canopy Growth Corporation (NASDAQ:CGC) rose 9.1% to $0.5651.
- IronNet, Inc. (NYSE:IRNT) climbed 8.6% to $0.2255.
- CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) jumped 8.6% to $8.62 after the company announced it achieved a milestone and will received $10 million from AbbVie in accordance with its regenerative dermal filler product collaboration agreement.
- Bruush Oral Care Inc. (NASDAQ:BRSH) shares climbed 8.3% to $0.3303 after declining around 4% on Friday.
- Belite Bio, Inc (NASDAQ:BLTE) gained 8% to $12.18.
- Genesco Inc. (NYSE:GCO) climbed 7.3% to $25.68. Genesco said its board of directors had authorized a $50 million increase to its existing $200 million share repurchase authorization.
Losers
- Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares dipped 85.7% to $0.6333 after the company's Phase 2 Peak trial For quisovalimab In patients With non-eosinophilic asthma missed its primary endpoint
- FibroGen, Inc. (NASDAQ:FGEN) dipped 80% to $3.2098 after the company's Phase 3 ZEPHYRUS-1 trial of pamrevlumab failed to meet its primary endpoint in idiopathic pulmonary fibrosis patients.
- Hitek Global Inc. (NASDAQ:HKIT) fell 23.8% to $4.11.
- Surgalign Holdings, Inc. (NASDAQ:SRGA) fell 22.4% to $0.2170 after jumping over 38% on Friday. Surgalign received NASDAQ delisting notice following Chapter 11 filing.
- Super Group (SGHC) Limited (NASDAQ:SGHC) dipped 19.6% to $3.0650. Super Group joined Russell 2000 Index.
- GSR II Meteora Acquisition Corp. (NASDAQ:GSRM) dropped 18.1% to $5.61.
- OneConnect Financial Technology Co., Ltd. (NYSE:OCFT) fell 17.4% to $3.3858.
- Nikola Corporation (NASDAQ:NKLA) dropped 17% to $1.0650.
- Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) fell 16.2% to $2.63 after jumping 48% on Friday.
- Lion Group Holding Ltd. (NASDAQ:LGHL) dropped 15.8% to $0.1219.
- Nauticus Robotics, Inc. (NASDAQ:KITT) fell 15.7% to $1.94. Nauticus Robotics announced inclusion in Russell Microcap® Index.
- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) dropped 15.2% to $0.2094.
- Diversified Healthcare Trust (NASDAQ:DHC) fell 14.6% to $1.69. Diversified Healthcare Trust issued monthly SHOP performance update.
- Biomea Fusion, Inc. (NASDAQ:BMEA) dropped 15.3% to $25.98 after the company announced new clinical data from the first two cohorts of Phase 2 portion of its ongoing Phase 1/2 study of BMF-219 in type 2 diabetes patients.
- Doma Holdings Inc. (NYSE:DOMA) fell 14.4% to $0.1908.
- Bio-Path Holdings, Inc. (NASDAQ:BPTH) dropped 13.4% to $1.80.
- Intapp, Inc. (NASDAQ:INTA) dropped 12.7% to $41.19.
- Skillz Inc. (NYSE:SKLZ) fell 12% to $8.29.
- Scholar Rock Holding Corporation (NASDAQ:SRRK) dropped 11.7% to $7.93.
- Sify Technologies Limited (NASDAQ:SIFY) tumbled 11.4% to $1.63.
- Carnival Corporation (NYSE:CCL) fell 9% to $14.38 after the company reported second-quarter financial results and issued guidance.
- Mercury Systems, Inc. (NASDAQ:MRCY) shares dropped 8.2% to $31.97 after the company said it reviewed strategic alternatives and decided to pursue a standalone strategy which includes finding a new CEO.
- SCWorx Corp. (NASDAQ:WORX) fell 7.6% to $0.4825 after jumping 45% on Friday.
- Bit Brother Limited (NASDAQ:BTB) fell 7.4% to $0.63 after gaining around 24% on Friday.
- Babylon Holdings Limited (NYSE:BBLN) fell 7.2% to $0.7149 after surging 24% on Friday. Babylon agreed to be acquired by AlbaCore Capital, MindMaze Group.
Now Read This: Bitcoin, Ethereum Record Gains; NEAR Protocol Emerges As Top Gainer